Cutaneous pseudolymphoma
ORPHA:451607Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder
ORPHA:477787Dianzani autoimmune lymphoproliferative disease
ORPHA:275523Diffuse large B-cell lymphoma
ORPHA:544Diffuse large B-cell lymphoma of the central nervous system
ORPHA:300849Diffuse large B-cell lymphoma with chronic inflammation
ORPHA:300888Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation
ORPHA:309515Disorder of pentose phosphate metabolism
ORPHA:79186Disorder of phospholipids, sphingolipids and fatty acids biosynthesis
ORPHA:352301Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement
ORPHA:352306Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement
ORPHA:352309Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement
ORPHA:352312Dominant hypophosphatemia with nephrolithiasis or osteoporosis
ORPHA:244305Dystonia-aphonia syndrome
ORPHA:412217EBV susceptibility with hemophagocytic lymphohistiocytosis as a major feature
ORPHA:664734EBV-induced lymphoproliferative disease due to CARMIL2 deficiency
ORPHA:542301EBV-induced lymphoproliferative disease due to CD137 deficiency
ORPHA:664726EBV-induced lymphoproliferative disease due to CD70 deficiency
ORPHA:538958EBV-induced lymphoproliferative disease due to PRKCD deficiency
ORPHA:664711EBV-induced lymphoproliferative disease due to RASGRP1 deficiency
ORPHA:664699EBV-induced lymphoproliferative disease due to TET2 deficiency
ORPHA:664729Enteropathy-associated T-cell lymphoma
ORPHA:86880Epithelioid trophoblastic tumor
ORPHA:254698Epstein-Barr virus-associated malignant lymphoproliferative disorder
ORPHA:289644Epstein-Barr virus-positive diffuse large B-cell lymphoma
ORPHA:289661Extranodal nasal NK/T cell lymphoma
ORPHA:86879Familial calcium pyrophosphate deposition
ORPHA:1416Familial hemophagocytic lymphohistiocytosis
ORPHA:540Familial hyperinflammatory lymphoproliferative immunodeficiency
ORPHA:619953Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome
ORPHA:306661Familial normophosphatemic tumoral calcinosis
ORPHA:306658Familial scaphocephaly syndrome
ORPHA:169163Familial scaphocephaly syndrome, McGillivray type
ORPHA:168624Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
ORPHA:168566Follicular lymphoma
ORPHA:545Fructose-1,6-bisphosphatase deficiency
ORPHA:348Genetic tumor of hematopoietic and lymphoid tissues
ORPHA:322126Gestational trophoblastic disease
ORPHA:254685Gestational trophoblastic neoplasm
ORPHA:59305Glycogen storage disease due to glucose-6-phosphatase deficiency
ORPHA:364Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
ORPHA:79258Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
ORPHA:79259Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency
ORPHA:79240Glycogen storage disease due to liver glycogen phosphorylase deficiency
ORPHA:369Glycogen storage disease due to liver phosphorylase kinase deficiency
ORPHA:264580Glycogen storage disease due to muscle glycogen phosphorylase deficiency
ORPHA:368Glycogen storage disease due to muscle phosphofructokinase deficiency
ORPHA:371Glycogen storage disease due to muscle phosphorylase kinase deficiency
ORPHA:715